Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

Go back to Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
(NASDAQ: KNSA) Delayed: 57.13 +2.02 (3.67%)
Previous Close $55.11    52 Week High
Open $55.69    52 Week Low
Day High $57.81    P/E N/A 
Day Low $55.69    EPS
Volume 608,365